Sage Therapeutic Com (NQ: SAGE )
8.140
-0.160
(-1.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Sage Therapeutic Com
![](https://mms.businesswire.com/media/20230307006059/en/1733055/5/Biogen_Logo_Standard.jpg)
![](https://mms.businesswire.com/media/20230228006229/en/1442032/5/Sage_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230221005933/en/1442032/5/Sage_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Sage Therapeutics
December 06, 2022
Via Benzinga
Sage Therapeutics's Return On Capital Employed Insights
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/17/aapharma_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230215005948/en/1442032/5/Sage_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/06/biib_co.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230205005025/en/1705452/5/Biogen_Logo_Standard.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://mms.businesswire.com/media/20230201006095/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20230108005038/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20230103005159/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20221205005815/en/1655671/5/Biogen_Logo_Standard.jpg)
![](https://mms.businesswire.com/media/20221123005005/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20221121005978/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20221109005349/en/1442032/5/Sage_Logo.jpg)
Sage Therapeutics to Present at the Stifel 2022 Healthcare Conference
November 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221108005333/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20221031005839/en/1442032/5/Sage_Logo.jpg)
From Sage Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221025005315/en/1442032/5/Sage_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221017005338/en/1603321/5/Biogen_Logo_Standard.jpg)
![](https://pressreach.com/wp-content/uploads/2022/09/five-red-mushrooms-fungi-34621701.jpg)
![](https://mms.businesswire.com/media/20220918005062/en/1575234/5/Biogen_Logo_Standard.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://mms.businesswire.com/media/20220902005053/en/1442032/5/Sage_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.